Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.
Invasive fungal infections in children appear to have increased over the past few decades. Substantial differences compared with adult patients in risk factors, pathogen epidemiology, pathophysiology and, most notably, pharmacokinetics of antifungal agents require age-adapted management and treatment approaches. The present article reviews these aspects for invasive aspergillosis and invasive candidiasis, the two most common life-threatening fungal infections.
Lass-Flörl
Cornelia
C
Department of Hygiene, Microbiology and Social Medicine, Fritz Pregl Str 3, 6020 Innsbruck, Austria. cornelia.lass-floerl@i-med.ac.at
D000367:Age Factors; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D054796:Drug Dosage Calculations; D006801:Humans; D007223:Infant; D007231:Infant, Newborn
D000935:Antifungal Agents